Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Taysha Gene Therapies (TSHA) Non Operating Income: 2020-2024

Historic Non Operating Income for Taysha Gene Therapies (TSHA) over the last 5 years, with Dec 2024 value amounting to $2.2 million.

  • Taysha Gene Therapies' Non Operating Income rose 245.19% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year decrease of 96.78%. This contributed to the annual value of $2.2 million for FY2024, which is 105.52% up from last year.
  • Per Taysha Gene Therapies' latest filing, its Non Operating Income stood at $2.2 million for FY2024, which was up 105.52% from -$39.1 million recorded in FY2023.
  • Over the past 5 years, Taysha Gene Therapies' Non Operating Income peaked at $2.2 million during FY2024, and registered a low of -$39.1 million during FY2023.
  • Over the past 3 years, Taysha Gene Therapies' median Non Operating Income value was -$3.6 million (recorded in 2022), while the average stood at -$13.5 million.
  • Its Non Operating Income has fluctuated over the past 5 years, first tumbled by 996.92% in 2023, then skyrocketed by 105.52% in 2024.
  • Taysha Gene Therapies' Non Operating Income (Yearly) stood at -$17.0 million in 2020, then soared by 92.62% to -$1.3 million in 2021, then slumped by 184.00% to -$3.6 million in 2022, then plummeted by 996.92% to -$39.1 million in 2023, then surged by 105.52% to $2.2 million in 2024.